2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts

Wagner F, Meier C, Krumbholz M, Metzler M, Mackensen A, Müller F (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 216-217

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Franziska Gsottberger Department of Medicine 5 – Haematology and Oncology Manuela Krumbholz Department of Paediatrics and Adolescent Medicine Markus Metzler Professur für Kinder- und Jugendmedizin mit dem Schwerpunkt Pädiatrische Onkologie und Hämatologie Andreas Mackensen Lehrstuhl für Innere Medizin V Fabian Müller Department of Medicine 5 – Haematology and Oncology

How to cite

APA:

Wagner, F., Meier, C., Krumbholz, M., Metzler, M., Mackensen, A., & Müller, F. (2019). 2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts. In ONCOLOGY RESEARCH AND TREATMENT (pp. 216-217). BASEL: KARGER.

MLA:

Wagner, Franziska, et al. "2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2019. 216-217.

BibTeX: Download